Parental consent for newborn screening in southern Taiwan

Mei-Chih Huang, Chia-Kuei Lee, S. J. Lin, I. C. Lu

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objects: With the advent of genetic technologies, many genetic/metabolic disorders can be detected asymptomatically but might be untreatable, and the benefits and risks of screening for them are not fully known. The purpose of this study is to explore current practice with regard to the parental consent process in newborn screening (NBS). Design: Staff in 23 obstetric clinics/hospitals that conduct NBS in one city of southern Taiwan were interviewed. Using content analysis, 15 interview transcripts, eight completed questionnaires, and other relevant documents from the 23 clinics/hospitals were analysed to reveal the framework of the parental consent process in NBS in southern Taiwan. Main measures: Three categories - informed consent, informed dissent, and no informed/consent - were developed to analyse the parental consent process in NBS. Results: The parental consent procedures in NBS and the quality of the information provided before obtaining consent vary widely. Because the traditional NBS was incorporated into routine paediatric practices in most clinics/hospitals, the most frequently encountered consent model is "informed dissent" (60.9%) and "no informed/consent" (30.4%); while an "informed consent" model (45.5%) is the frequent model for screening rare metabolic/genetic disorders. Conclusions: Specific guidelines to regulate the parental consent process for NBS are essential. Further studies should investigate parental responses to NBS, taking these as the basis on which to establish an informed consent model in Taiwan.

Original languageEnglish
Pages (from-to)621-624
Number of pages4
JournalJournal of Medical Ethics
Volume31
Issue number11
DOIs
Publication statusPublished - 2005 Nov 1

Fingerprint

Parental Consent
Taiwan
Newborn Infant
Informed Consent
Inborn Genetic Diseases
Dissent and Disputes
obstetrics
content analysis
staff
Consent
Newborn
Screening
questionnaire
interview
Obstetrics
Guidelines
Interviews
Pediatrics
Technology

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Issues, ethics and legal aspects
  • Arts and Humanities (miscellaneous)
  • Health Policy

Cite this

@article{25d2ea35b5f14a3d9c8ce1743a046bcb,
title = "Parental consent for newborn screening in southern Taiwan",
abstract = "Objects: With the advent of genetic technologies, many genetic/metabolic disorders can be detected asymptomatically but might be untreatable, and the benefits and risks of screening for them are not fully known. The purpose of this study is to explore current practice with regard to the parental consent process in newborn screening (NBS). Design: Staff in 23 obstetric clinics/hospitals that conduct NBS in one city of southern Taiwan were interviewed. Using content analysis, 15 interview transcripts, eight completed questionnaires, and other relevant documents from the 23 clinics/hospitals were analysed to reveal the framework of the parental consent process in NBS in southern Taiwan. Main measures: Three categories - informed consent, informed dissent, and no informed/consent - were developed to analyse the parental consent process in NBS. Results: The parental consent procedures in NBS and the quality of the information provided before obtaining consent vary widely. Because the traditional NBS was incorporated into routine paediatric practices in most clinics/hospitals, the most frequently encountered consent model is {"}informed dissent{"} (60.9{\%}) and {"}no informed/consent{"} (30.4{\%}); while an {"}informed consent{"} model (45.5{\%}) is the frequent model for screening rare metabolic/genetic disorders. Conclusions: Specific guidelines to regulate the parental consent process for NBS are essential. Further studies should investigate parental responses to NBS, taking these as the basis on which to establish an informed consent model in Taiwan.",
author = "Mei-Chih Huang and Chia-Kuei Lee and Lin, {S. J.} and Lu, {I. C.}",
year = "2005",
month = "11",
day = "1",
doi = "10.1136/jme.2004.010074",
language = "English",
volume = "31",
pages = "621--624",
journal = "Journal of Medical Ethics",
issn = "0306-6800",
publisher = "BMJ Publishing Group",
number = "11",

}

Parental consent for newborn screening in southern Taiwan. / Huang, Mei-Chih; Lee, Chia-Kuei; Lin, S. J.; Lu, I. C.

In: Journal of Medical Ethics, Vol. 31, No. 11, 01.11.2005, p. 621-624.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Parental consent for newborn screening in southern Taiwan

AU - Huang, Mei-Chih

AU - Lee, Chia-Kuei

AU - Lin, S. J.

AU - Lu, I. C.

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Objects: With the advent of genetic technologies, many genetic/metabolic disorders can be detected asymptomatically but might be untreatable, and the benefits and risks of screening for them are not fully known. The purpose of this study is to explore current practice with regard to the parental consent process in newborn screening (NBS). Design: Staff in 23 obstetric clinics/hospitals that conduct NBS in one city of southern Taiwan were interviewed. Using content analysis, 15 interview transcripts, eight completed questionnaires, and other relevant documents from the 23 clinics/hospitals were analysed to reveal the framework of the parental consent process in NBS in southern Taiwan. Main measures: Three categories - informed consent, informed dissent, and no informed/consent - were developed to analyse the parental consent process in NBS. Results: The parental consent procedures in NBS and the quality of the information provided before obtaining consent vary widely. Because the traditional NBS was incorporated into routine paediatric practices in most clinics/hospitals, the most frequently encountered consent model is "informed dissent" (60.9%) and "no informed/consent" (30.4%); while an "informed consent" model (45.5%) is the frequent model for screening rare metabolic/genetic disorders. Conclusions: Specific guidelines to regulate the parental consent process for NBS are essential. Further studies should investigate parental responses to NBS, taking these as the basis on which to establish an informed consent model in Taiwan.

AB - Objects: With the advent of genetic technologies, many genetic/metabolic disorders can be detected asymptomatically but might be untreatable, and the benefits and risks of screening for them are not fully known. The purpose of this study is to explore current practice with regard to the parental consent process in newborn screening (NBS). Design: Staff in 23 obstetric clinics/hospitals that conduct NBS in one city of southern Taiwan were interviewed. Using content analysis, 15 interview transcripts, eight completed questionnaires, and other relevant documents from the 23 clinics/hospitals were analysed to reveal the framework of the parental consent process in NBS in southern Taiwan. Main measures: Three categories - informed consent, informed dissent, and no informed/consent - were developed to analyse the parental consent process in NBS. Results: The parental consent procedures in NBS and the quality of the information provided before obtaining consent vary widely. Because the traditional NBS was incorporated into routine paediatric practices in most clinics/hospitals, the most frequently encountered consent model is "informed dissent" (60.9%) and "no informed/consent" (30.4%); while an "informed consent" model (45.5%) is the frequent model for screening rare metabolic/genetic disorders. Conclusions: Specific guidelines to regulate the parental consent process for NBS are essential. Further studies should investigate parental responses to NBS, taking these as the basis on which to establish an informed consent model in Taiwan.

UR - http://www.scopus.com/inward/record.url?scp=28244437155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28244437155&partnerID=8YFLogxK

U2 - 10.1136/jme.2004.010074

DO - 10.1136/jme.2004.010074

M3 - Article

VL - 31

SP - 621

EP - 624

JO - Journal of Medical Ethics

JF - Journal of Medical Ethics

SN - 0306-6800

IS - 11

ER -